Articles


Ehlers-Danlos & Joint Hypermobility Syndroms

Prolotherapy Effective for Ehlers-Danlos & Joint Hypermobility Syndromes

Posted on August 9 By Oregon Regenerative Medicine

Ehlers-Danlos Syndrome and Joint Hypermobility Syndrome (EDS/JHS) affects 1 in 5,000 people in the US. The condition is either inherited from a parent or caused by a genetic mutation. The hallmark traits of this affliction are connective tissue abnormalities or defects in the proteins that … Learn More » “Prolotherapy Effective for Ehlers-Danlos & Joint Hypermobility Syndromes”